D.E. Shaw & Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.79M | Sell |
142,700
-238,400
| -63% | -$12.6M | ﹤0.01% | 1951 |
|
|
2025
Q4 | $20M | Buy |
381,100
+20,800
| +6% | +$1.25M | 0.01% | 1243 |
|
|
2025
Q3 | $23.4M | Buy |
360,300
+226,700
| +170% | +$13M | 0.01% | 1077 |
|
|
2025
Q2 | $6.5M | Buy |
133,600
+82,200
| +160% | +$3.18M | ﹤0.01% | 1825 |
|
|
2025
Q1 | $1.75M | Sell |
51,400
-23,500
| -31% | -$996K | ﹤0.01% | 2708 |
|
|
2024
Q4 | $2.95M | Buy |
74,900
+15,600
| +26% | +$737K | ﹤0.01% | 2411 |
|
|
2024
Q3 | $2.79M | Sell |
59,300
-7,300
| -11% | -$370K | ﹤0.01% | 2438 |
|
|
2024
Q2 | $3.6M | Sell |
66,600
-151,900
| -70% | -$8.79M | ﹤0.01% | 2112 |
|
|
2024
Q1 | $14.9M | Buy |
218,500
+57,600
| +36% | +$4.12M | 0.01% | 1109 |
|
|
2023
Q4 | $10.1M | Buy |
160,900
+68,400
| +74% | +$3.78M | 0.01% | 1361 |
|
|
2023
Q3 | $4.2M | Hold |
92,500
| – | – | ﹤0.01% | 1956 |
|
|
2023
Q2 | $5.19M | Sell |
92,500
-18,000
| -16% | -$1.02M | 0.01% | 1836 |
|
|
2023
Q1 | $5M | Sell |
110,500
-37,900
| -26% | -$1.84M | 0.01% | 1938 |
|
|
2022
Q4 | $6.03M | Buy |
148,400
+32,500
| +28% | +$1.72M | 0.01% | 1912 |
|
|
2022
Q3 | $7.57M | Hold |
115,900
| – | – | 0.01% | 1618 |
|
|
2022
Q2 | $7.04M | Buy |
115,900
+48,000
| +71% | +$2.82M | 0.01% | 1748 |
|
|
2022
Q1 | $4.26M | Sell |
67,900
-2,000
| -3% | -$126K | ﹤0.01% | 2506 |
|
|
2021
Q4 | $5.3M | Buy |
69,900
+19,900
| +40% | +$1.74M | ﹤0.01% | 2307 |
|
|
2021
Q3 | $5.6M | Buy |
50,000
+10,000
| +25% | +$1.26M | 0.01% | 2003 |
|
|
2021
Q2 | $6.48M | Buy |
40,000
+30,000
| +300% | +$3.65M | 0.01% | 1838 |
|
|
2021
Q1 | $1.22M | Sell |
10,000
-10,000
| -50% | -$1.51M | ﹤0.01% | 2965 |
|
|
2020
Q4 | $3.06M | Buy |
20,000
+10,000
| +100% | +$1.18M | ﹤0.01% | 2254 |
|
|
2020
Q3 | $836K | Hold |
10,000
| – | – | ﹤0.01% | 2963 |
|
|
2020
Q2 | $735K | Hold |
10,000
| – | – | ﹤0.01% | 3132 |
|
|
2020
Q1 | $424K | Hold |
10,000
| – | – | ﹤0.01% | 3288 |
|
|
2019
Q4 | $609K | Buy |
+10,000
| New | +$546K | ﹤0.01% | 3289 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
